CNBC's Meg Tirrell reports Texas health officials have confirmed the Ebola patient is in Texas, and had a recent history of travel to West Africa.
Shares of pharmaceutical companies working on a drug to treat Ebola spiked after the CDC confirmed the first case diagnosed in the U.S.
The CDC has confirmed the first Ebola case diagnosed in the U.S. The "Fast Money" traders discuss the companies spiking on the news.
The CDC has confirmed the first Ebola case diagnosed in the U.S. and will hold a news conference at 5:30PM E.T. Tuesday. CNBC's Meg Tirrell has the details.
The CDC will hold a news conference on a U.S. Ebola case at 5:30PM E.T., reports CNBC's Dominic Chu.
Former NFL quarterback Joe Namath is taking on the fight against debilitating effects of brain injuries.
A breast cancer drug from Roche known as Perjeta helped patients live nearly 16 months longer compared with Herceptin and chemotherapy alone. CNBC's Meg Tirrell provides insight to the data.
The World Bank on Thursday announced it would give another $170 million to help West African countries contain the spread of the Ebola virus.
CNBC's Meg Tirell reports the latest projections on the Ebola virus.
The world's attention may have shifted to U.S. airstrikes on Syria, but West Africa continues to be ravaged by the worst outbreak of Ebola.
CNBC's Meg Tirrell runs down today's top health care headlines, including a major move by President Obama to fight the Ebola virus and the latest on Enterovirus D68.
CNBC's Meg Tirrell speaks to Johnson & Johnson chairman, Joaquin Duato, about J&J's partnership with the National Institutes of Health to fast track its Ebola vaccine program to begin human testing by early 2015.
Discussing the new ways to monitor glucose for people with diabetes, and competition in the space, with Terry Gregg, DexCom CEO. Gregg says his business is in conversations with Apple and Samsung in regards to partnering on wearables.
CNBC's Meg Tirrell reports experimental cholesterol medicines by Amgen and Regeneron represent a potential $10 billion opportunity pending FDA approval in the U.S.
A new class of drugs which aim to lower levels of LDL are being pursued by multiple pharma companies and it could be a $10 billion market. Leonard Schleifer, Regeneron CEO, discusses what is known about bad cholesterol, and competition in the space.
GlaxoSmithKline is to begin human testing of an experimental Ebola vaccine. CNBC's Meg Tirrell reports the World Health Organization has released a response roadmap with the goal of stopping the spread of Ebola in 6 to 9 months.
The trials will start at the NIH in Maryland. A vaccine is "the first step in a long process" to control Ebola, Dr. Anthony Fauci says. NBC reports.
Nigeria's health minister has insisted the Ebola outbreak has been contained in the country.
CNBC's Meg Tirrell breaks down the mega deal between Swiss pharmaceutical firm Roche and InterMune for $8.3 billion.
CNBC's Meg Tirrell speaks to Roche CEO Severin Schwan, and InterMune CEO Daniel Welch, about Roche's $8.3 billion acquisition of InterMune and the opportunity for the drug Esbriet in the U.S.